Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients

Triple Negative Breast Cancers (TNBC) subtype is an aggressive disease with poor clinical outcome. The only treatment available is surgery followed by chemotherapy or radiotherapy. Programmed death-ligand 1 (PD-L1) is a trans-membrane protein expressed on a wide variety of cells including immune cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Botti, Gerardo, Collina, Francesca, Scognamiglio, Giosuè, Rao, Federica, Peluso, Valentina, De Cecio, Rossella, Piezzo, Michela, Landi, Gabriella, De Laurentiis, Michelino, Cantile, Monica, Di Bonito, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343992/
https://www.ncbi.nlm.nih.gov/pubmed/28230773
http://dx.doi.org/10.3390/ijms18020459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343992/
https://www.ncbi.nlm.nih.gov/pubmed/28230773
http://dx.doi.org/10.3390/ijms18020459

Ejemplares similares